Experiences with
Age-related cataracts1,754 public posts
Webinar: New approved treatment for wet AMD
Lytenava (bevacizumab gamma), is the first licensed version of Avastin for wet age-related macular degeneration. The treatment was approved by the National Institute for Health and Care Excellence (NICE) for use in the NHS last year.
Join our monthly webinar as professor Andrew Lotery will break down
Want to take advantage of all our features? Just log in!
or